Amylyx Pharmaceuticals, Inc.
AMLX
$14.05
$0.261.89%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 316.98M | 343.99M | 180.83M | 204.07M | 176.50M |
| Total Receivables | 188.00K | 232.00K | 203.00K | 300.10K | 547.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.50M | 9.16M | 5.86M | 11.78M | 12.38M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 323.67M | 353.38M | 186.89M | 216.14M | 189.43M |
|
|
|||||
| Total Current Assets | 323.67M | 353.38M | 186.89M | 216.14M | 189.43M |
| Net Property, Plant & Equipment | 5.49M | 5.88M | 6.26M | 2.07M | 2.73M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.48M | 3.48M | 1.45M | 1.46M | 1.47M |
| Total Assets | 332.65M | 362.74M | 194.60M | 219.68M | 193.63M |
|
|
|||||
| Total Accounts Payable | 3.52M | 5.34M | 3.29M | 4.81M | 2.94M |
| Total Accrued Expenses | 17.91M | 19.47M | 17.47M | 12.07M | 23.95M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.26M | 981.00K | 665.00K | 1.06M | 1.52M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 22.69M | 25.79M | 21.42M | 17.93M | 28.41M |
|
|
|||||
| Total Current Liabilities | 22.69M | 25.79M | 21.42M | 17.93M | 28.41M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.70M | 4.95M | 5.30M | 327.00K | 463.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 27.39M | 30.75M | 26.72M | 18.26M | 28.87M |
|
|
|||||
| Common Stock & APIC | 1.06B | 1.05B | 851.37M | 844.02M | 771.55M |
| Retained Earnings | -751.43M | -718.43M | -684.04M | -642.60M | -606.69M |
| Treasury Stock & Other | 404.00K | 815.00K | 551.00K | -- | -92.00K |
| Total Common Equity | 305.26M | 332.00M | 167.88M | 201.42M | 164.77M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 305.26M | 332.00M | 167.88M | 201.42M | 164.77M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 305.26M | 332.00M | 167.88M | 201.42M | 164.77M |
|
|
|||||